Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 2, 2026 · Filed Sep 4, 2026
An Illumina director sold $2.27M of Illumina shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$2,269,813
Shares × reported transaction price
34 days after results of Jul 30, 2026, 57 days before results of Oct 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $213.25 on Sep 2, 2026, 134% above its 52-week low and 6% below its high, after a 12% rise over the previous 30 trading days
52-week range $91.00 (Oct 14, 2025) to $227.69 (Aug 27, 2026), 89% of the way up, from 252 adjusted closes. 30 trading days earlier: $190.87 on Jul 22, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Dec 21, 2023 in the U.S. District Court, S.D. California. A filing is an allegation, not a finding.
3 such cases were open. Louisiana Sheriffs' Pension & Relief Fund v. Illumina, Inc., docket 3:23-cv-02328, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.3% | −1.1% | +6.4% |
| 30 days | +25.4% | +1.0% | +24.3% |
Past results only. Not a forecast.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Federal contracts
"eo 14398" five (5) genomic sequencing systems miseq I100 plus systems
The Department of Health and Human Services has committed $575K to Illumina so far. The contract could grow to $871K. It runs until Nov 16, 2027.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.